242 related articles for article (PubMed ID: 335518)
21. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases.
Lukes RJ; Parker JW; Taylor CR; Tindle BH; Cramer AD; Lincoln TL
Semin Hematol; 1978 Oct; 15(4):322-51. PubMed ID: 366759
[No Abstract] [Full Text] [Related]
22. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
24. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
Mathé G; Belpomme D; Dantchev D; Pouillart P
Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
[TBL] [Abstract][Full Text] [Related]
25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
26. [Delimitation of chronic lymphoid leukemia].
Rain JD; Preud'homme JL
Nouv Presse Med; 1973 Jan; 2(4):229-32. PubMed ID: 4568328
[No Abstract] [Full Text] [Related]
27. Surface markers for T and B lymphocytes in normals and patients with lymphoproliferative disorders.
Cohnen G; Augener W; Douglas SD; König E; Brittinger G
Boll Ist Sieroter Milan; 1974; 53(1):suppl:295. PubMed ID: 4605188
[No Abstract] [Full Text] [Related]
28. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
Bloomfield CD; Gajl-Peczalska KJ
Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
[No Abstract] [Full Text] [Related]
29. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
[No Abstract] [Full Text] [Related]
30. Correlation of tumor cell kinetic studies with surface marker results in childhood non-Hodgkin's lymphoma.
Murphy SB; Melvin SL; Mauer AM
Cancer Res; 1979 May; 39(5):1534-8. PubMed ID: 311685
[No Abstract] [Full Text] [Related]
31. [Immunoblastic sarcoma and related lymphoproliferative diseases (proceedings)].
Marmont A; Damasio E; Santini G; Carella M
Minerva Med; 1977 Oct; 68(51):3515-6. PubMed ID: 303751
[No Abstract] [Full Text] [Related]
32. Binding of aggregated IgG by lymphocytes in chronic lymphocytic leukemia.
Augener W; Cohnen G; Brittinger G
Biomedicine; 1974 Jan; 21(1):6-8. PubMed ID: 4602945
[No Abstract] [Full Text] [Related]
33. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
34. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
[No Abstract] [Full Text] [Related]
35. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
[No Abstract] [Full Text] [Related]
36. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
Dorlhiac P; Genter G; Jamra M
Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
[No Abstract] [Full Text] [Related]
37. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
[TBL] [Abstract][Full Text] [Related]
38. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow and peripheral blood involvement in non-Hodgkin's lymphomas.
Brunning RD
Geriatrics; 1975 Oct; 30(10):75-80. PubMed ID: 1098960
[No Abstract] [Full Text] [Related]
40. T and B cell populations in blood and lymph node in lymphoproliferative disease.
Cooper DA; Petts V; Luckhurst E; Biggs JC; Penny R
Br J Cancer; 1975 May; 31(5):550-8. PubMed ID: 1080424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
